Results 251 to 260 of about 117,129 (304)

Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus

Signal Transduction and Targeted Therapy
Yumin Zhang, Sheng Tang, Lu Chen, Shufen Song, Junyuan Cao, Guanghui Tian, Gengfu Xiao, Jingshan Shen, Leike Zhang   +8 more
doaj   +1 more source

Isolation of Huangpi tick virus 1 and assessment of potential zoonotic relevance. [PDF]

Parasit Vectors
Fu L, Li C, Ni J, Qian J, Xiao J, Zhu Q, Huang S, Xiong J, Chen Q, Guan X, Fang R, Fen D, Tang S, Deng F, Liu D, Shen S, Wu X.   +16 more
europepmc   +1 more source

FAO laboratory mapping tool results analysis for veterinary laboratories from 2012 to 2020: highlights of the gaps, the strengths across Southeast Asia and implications for capacity building activities. [PDF]

Front Vet Sci
Gourlaouen M, Blacksell SD, Kim Le K, Morrissy CJ, Kalpravidh W, Wongsathapornchai K, Motta P, Rangkuti A, Dauphin G, Wiersma L, Tran T, Porfiri L, Mouillé B, Claes F.   +13 more
europepmc   +1 more source

Production of proteins in plants by means of viral full-length clones under biosafety aspects

, 2004
Manske, Ulrike, Schiemann, Joachim
core  

Some of the next articles are maybe not open access.

Related searches:

Biosafety and biosecurity measures: management of biosafety level 3 facilities

International Journal of Antimicrobial Agents, 2010
With the increasing biological threat from emerging infectious diseases and bioterrorism, it has become essential for governments around the globe to increase awareness and preparedness for identifying and containing those agents. This article introduces the basic concepts of laboratory management, laboratory biosafety and laboratory biosecurity ...
exaly   +3 more sources

Biosafety of Adenoviral Vectors

Current Gene Therapy, 2003
Adenoviral vectors can efficiently transduce a broad variety of different cell types and have been used extensively in preclinical and clinical studies. However, early generation of adenoviral vectors retained residual adenoviral genes that contribute to inflammatory immune responses and toxicity.
Chuah, Marinee K L, Collen, Desire, VandenDriessche, Thierry   +2 more
openaire   +3 more sources

Biosafety of Prions

2017
Prions are the infectious agents that cause devastating and untreatable disorders known as Transmissible Spongiform Encephalopathies (TSEs). The pathologic events and the infectious nature of these transmissible agents are not completely understood yet.
Bistaffa E., Rossi M., De Luca C. M. G., Moda F.   +3 more
openaire   +3 more sources

The ecology and biosafety of baculoviruses

Current Opinion in Biotechnology, 1997
Advances in the use of molecular techniques-particularly for virus identification, the investigation of latency and the infection process, plus the development of a theoretical framework containing a higher degree of biological realism-have pushed baculovirus ecology forward in the past few years.
J S, Cory, R S, Hails
openaire   +2 more sources

Biosafety of Herpesvirus Vectors

Current Gene Therapy, 2003
Herpesviruses are large DNA viruses, which possess a number of advantages as gene delivery vectors. These relate to an ability to package large DNA insertions and establish lifelong latent infections in which the viral genome exists as a stable episome in the nucleus.
Gogev, S., Schynts, F., Meurens, F., Bourgot, I., Thiry, Etienne   +4 more
openaire   +2 more sources

Biosafety and Selectable Markers

Annals of the New York Academy of Sciences, 2007
Abstract:  Francisella tularensis (F. tularensis) is one of the most infectious pathogens known. Although the disease caused by this bacterium is rarely fatal with appropriate antibiotic therapy, it is often severely debilitating. Laboratory work with F.
Richard W, Titball, Anders, Sjostedt, Martin S, Pavelka, Francis E, Nano   +3 more
openaire   +2 more sources